UMB Bank’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.29K Buy
66
+46
+230% +$1.68K ﹤0.01% 2185
2026
Q2
$789 Sell
20
-66
-77% -$2.66K ﹤0.01% 2269
2026
Q1
$3.83K Buy
+86
New +$3.8K ﹤0.01% 2076

Other funds holding MDLN

UMB Bank's MDLN Position: Q3 2026 in Review

UMB Bank increased its Medline (MDLN) stake by 230% in Q3 2026, buying an estimated $1.68K and bringing the position to 66 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

UMB Bank first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.83K in Q1 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • UMB Bank held 66 shares of Medline worth $2.29K as of Q3 2026.
  • UMB Bank bought 46 Medline shares in Q3 2026, an estimated $1.68K.
  • Medline made up ﹤0.01% of UMB Bank's portfolio in Q3 2026, its #2185 holding.
  • UMB Bank first reported a position in Medline in Q1 2026 and has held it in 3 quarters since.
  • UMB Bank's Medline position peaked at $3.83K in Q1 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on UMB Bank's 13F filing for Q3 2026, filed 6 Nov 2026.